In our analysis no association between other tested polymorphisms (rs1799750 in MMP-1, rs243865 in MMP-2, rs2252070 in MMP-13 and rs28366003 in MT2A) and prostate cancer risk was shown. Here, MMP13 is linked to prostate carcinoma.